This inventor holds 5 USPTO granted patents. Top assignees: Rutgers, The State University of New Jersey, Alcatel Lucent, Stratasys, Inc.. Active years: 1998-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Robbinsville, NJ (US) (1998 - 1999)
- West Windsor, NJ (US) (2013 - 2017)
Company Filing History:



Years Active: 1998-2017
Title: Noshir Langrana: Innovator in Biomaterials and Drug Delivery Systems
Introduction
Noshir Langrana is a prominent inventor based in West Windsor, NJ (US), known for his significant contributions to the fields of biomaterials and drug delivery systems. With a total of five patents to his name, Langrana has made strides in developing innovative solutions that address critical medical challenges.
Latest Patents
Among his latest patents, Langrana has developed biomaterials and methods aimed at preventing post-operative adhesions. His work includes biofunctional films that serve this purpose effectively. Additionally, he has created an agent delivery system capable of selectively releasing an active agent within an organism. This composition features first and second polymer portions with functional groups that form cross-links, which can be broken by substances within the organism, allowing for controlled release of the active agent.
Career Highlights
Langrana has had a distinguished career, working with notable institutions such as Rutgers, the State University of New Jersey, and Alcatel Lucent. His experience in these organizations has contributed to his expertise in biomaterials and drug delivery technologies.
Collaborations
Some of his notable coworkers include Stephen C. Danforth and Mukesh Agarwala, who have collaborated with him on various projects, enhancing the impact of his innovations.
Conclusion
Noshir Langrana's work in biomaterials and drug delivery systems exemplifies the importance of innovation in addressing medical challenges. His patents reflect a commitment to improving patient outcomes through advanced technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile